Results 51 to 60 of about 866,587 (181)

Evaluating total lymphocyte counts as a substitute for CD4 counts in the follow up of AIDS patients [PDF]

Brazilian Journal of Infectious Diseases, 2007
This study evaluated total lymphocyte count (TLC) as a substitute marker for CD4+ cell counts to identify patients who need prophylaxis against opportunistic infection (CD4 < 200 cells/mm(3)) and patients with CD4 < 350 cells/mm(3) (Brazilian threshold value of CD4 count to define AIDS).
Angelo, Ana Luiza Dias, Angelo, Camila Dias, Torres, Alex José Leite, Ramos, André Maurício Costa, Lima, Márcia, Netto, Eduardo Martins, Brites, Carlos   +6 more
openaire   +5 more sources

Unadjusted CD4+ lymphocyte count change.

, 2013
Unadjusted CD4+ lymphocyte count following first HAART initiation for each woman (gray lines) and average increase (solid black line) by timing of HAART initiation.
Vlada V. Melekhin (307844), Peter F. Rebeiro (293350), Bryan E. Shepherd (173791), Timothy R. Sterling (148936), Stephen P. Raffanti (370632), Samuel E. Stinnette (293348), Gema Barkanic (352776)   +6 more
core   +1 more source

Multiple Immune Abnormalities in a Patient with Idiopathic CD4+ T-Lymphocytopenia [PDF]

, 2009
Idiopathic CD4+ T-lymphocytopenia (ICL) is a new disease entity characterized by CD4+ T-lymphocyte depletion without evidence of HIV infection. We report a 27-year-old ICL patient with a long history of multiple immune abnormalities.
Tsukasaki, Kunihiro, Hiroyuki Moriuchi, Masahiko Okada, Masanori Yanai, Kamitamari, Akira, Kamihira, Shimeru, Yasuaki Yamada, Hiroo Hasegawa, Hasegawa, Hiroo, Akira Kamitamari, Yamada, Yasuaki, Yanagihara, Katsunori, Kazuto Tsuruda, Kunihiro Tsukasaki, Katsunori Yanagihara, Osamu Hano, Okada, Masahiko, Shimeru Kamihira, Yanai, Masanori, Hano, Osamu, Moriuchi, Hiroyuki, Tsuruda, Kazuto   +21 more
core   +1 more source

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe [PDF]

, 2012
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.
Amurwon, Jovita, Abdel G. Babiker (158530), Darbyshire Janet, Antonieta Medina Lara (168787), Antonieta Medina Lara, Charles F. Gilks (164480), Munderi Paula, Wakaholi, Barbara Nyanzi, Walker, A Sarah, Babiker, AG, Elly Katabira, Paula Munderi, Reid Andrew, Kasirye, Ronnie, James Hakim, Andrew Reid, Gibb, Diana M., Janet Darbyshire (59117), Jesse Kigozi (168794), Katabira Elly, Gilks, CF, Gilks, Charles F, Kityo Cissy, Darbyshire, J, Jovita Amurwon, Cissy Kityo, Walker A. Sarah, Kigozi, Jesse, Mugyenyi Peter, Barbara Nyanzi Wakaholi, Gibb, DM, Mugyenyi, Peter, Lara, AM, Walker, AS, Muchabaiwa Lazarus, Reid, Andrew, Peter Mugyenyi (168847), Darbyshire, Janet, Diana M. Gibb (164420), Medina Lara Antonieta, Ssali Francis, Kityo, Cissy, Grosskurth Heiner, Grosskurth, Heiner, Abdel G Babiker, Ruben E. Mujica Mota (168817), Kasirye Ronnie, Nyanzi Wakaholi, B, Jesse Kigozi, Walker, Ann, Wakaholi, BN, Team, Ssali, Francis, Ssali, F, Lazarus Muchabaiwa, Medina Lara, Antonieta, Hakim James, Walker, A. Sarah, Peter Mugyenyi, Janet Darbyshire, Gilks, Charles F., Team, DARTT, DART Trial Team, Diana M Gibb, Muchabaiwa, L, Elly Katabira (10701), A Sarah Walker, Kasirye, R, Ronnie Kasirye (168825), Paula Munderi (164469), Katabira, Elly, Muchabaiwa, Lazarus, Munderi, P, Hakim, J, Gibb, Diana M, Barbara Nyanzi Wakaholi (168811), Mota, Ruben E. Mujica, Gilks Charles F., Amurwon Jovita, Jovita Amurwon (168800), James Hakim (164478), Babiker, Abdel G, Amurwon, J, Charles F Gilks, Kityo, C, Nyanzi Wakaholi, Barbara, Babiker, Abdel G., Gibb Diana M., Mota, REM, Cissy Kityo (168842), Mujica Mota, Ruben E, Heiner Grosskurth (37057), Ruben E Mujica Mota, Reid, A, Medina-Lara, A, Kigozi Jesse, Francis Ssali, Mujica Mota Ruben E., Andrew Reid (168831), A. Sarah Walker (145609), Heiner Grosskurth, Lara, Antonieta Medina, Katabira, E, Ronnie Kasirye, Munderi, Paula, Grosskurth, H, Hakim, James, Francis Ssali (158549), Mujica-Mota, Ruben, Lazarus Muchabaiwa (168805), Kigozi, J, Mugyenyi, P, Nyanzi Wakaholi Barbara, Babiker Abdel G.   +113 more
core   +1 more source

Absolute lymphocyte count as a marker for Cd4 T-lymphocyte count: criterion for initiating antiretroviral therapy in HIV infected Nigerians [PDF]

Nigerian Journal of Medicine, 2006
Few laboratories in resource-constrained countries can afford to perform laboratory-monitoring tests required for the implementation of HIV therapy. In this case control study, we have investigated the relevance of absolute lymphocyte count as a surrogate marker for CD4 lymphocyte count as a criterion for initiating HAARTin HIV-infected Nigerians.A ...
Adias Teddy C, Uko Emmanuel K, Erhabor Osaro   +2 more
openaire   +5 more sources

Possible Use of Absolute Lymphocyte Count as Surrogate for CD4+ Cells Count in Monitoring Response to Highly Active Antiretroviral Therapy in Sokoto.

Sokoto Journal of Medical Laboratory Science, 2016
Few laboratories in resource-constrained countries can afford to perform laboratory-monitoring tests required for the management of HIV therapy. The initiation of an antiretroviral therapy is based on CD4+ count less than 350 cells/mm3according to the ...
Onuigwe, F.U., Alimi, R., Balarabe, I., Uko, E., Uchechukwu, N.J., Erhabor, O.
doaj  

Concentration of white blood cells from whole blood by dual centrifugo-pneumatic siphoning with density gradient medium [PDF]

, 2012
Due to the pervasiveness of HIV infections in developing countries there exists a need for a low-cost, user-friendly point-of-care device which can be used to monitor the concentration of T-lymphocytes in the patient’s blood expressing the CD4+ epitope ...
Glynn, Macdara, Kearney, Sinéad M., Ducrée, Jens, Kinahan, David J.   +3 more
core   +2 more sources

Utility of absolute lymphocyte count as a surrogate marker of CD4 cell counts: Is it useful? [PDF]

Medical Journal Armed Forces India, 2014
Human immunodeficiency virus (HIV) management has witnessed paradigm changes over the past decade. In the early era, Absolute lymphocyte counts (ALC) were used as an inexpensive, indirect marker of immunity status. With time, CD4 lymphocyte counts and HIV RNA levels have become a standard of care for follow up of people living with HIV/AIDS (PLHA ...
Amitabh, Sagar, Abhishek, Pathak, Vikas, Ambiya, Nardeep, Naithani, Biju, Vasudevan, Sunil, Agrawal   +5 more
openaire   +2 more sources

Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana

AIDS Research and Treatment, 2011
Background. CD4+ T-lymphocyte monitoring is not routinely available in most resource-limited settings. We investigated predictors of time to CD4+ T-lymphocyte recovery in HIV-infected children on highly active antiretroviral (HAART) at Korle-Bu Teaching ...
Lorna Renner, Meghan Prin, Fang-Yong Li, Bamenla Goka, Veronika Northrup, Elijah Paintsil   +5 more
doaj   +1 more source

Correlation between Total Lymphocyte Count, Hemoglobin, Hematocrit and CD4 Count in HIV/AIDS Patients [PDF]

Acta Medica Iranica, 2009
Lymphocyte CD4+count, a standard laboratory test for staging of HIV infection, is expensive and unavailable in resource-restricted countries. Total lymphocyte count (TLC) and hemoglobin (Hb) are recommended as simple & inexpensive surrogates.
Seyed Mohammad Alavi, Fatemeh Ahmadi, Majid Farhadi   +2 more
doaj   +1 more source